SUBSCRIBE
SUBSCRIBE
News   Business

Glenmark Pharmaceuticals, Sanofi (France) in $345 Million Drug-Licensing Pact

May 3, 2010 | 
1 min read

WSJ -- India’s Glenmark Pharmaceuticals Ltd. said Monday it has agreed to license out development and commercialization rights of a painkiller it is developing to France’s Sanofi-Aventis S.A.

Alliances Asia
Sanofi (France)
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Stubborn Layoff Trend Continues Across Biopharma in 2024
December 23, 2024
 · 
207 min read
 · 
BioSpace Editorial Staff
Pictured: Eli Lilly Campus in San Diego
Drug shortages
FDA Confirms Lilly’s GLP-1s Are Not in Shortage, Gives Compounders Grace Period
December 19, 2024
 · 
3 min read
 · 
Tristan Manalac
Contemporary art collage of a hand holding scissors. Copy space for ad. Modern design.
Layoffs
Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs
December 19, 2024
 · 
1 min read
 · 
Annalee Armstrong
Business
Analysis vs Beliefs, CEO Challenges, GLP-1 Investments
December 19, 2024
 · 
1 min read
 · 
Lori Ellis